<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <latestAction>
      <text>Referred to the House Committee on Energy and Commerce.</text>
      <actionDate>2016-12-07</actionDate>
      <links />
    </latestAction>
    <amendments />
    <billNumber>6463</billNumber>
    <summaries>
      <billSummaries>
        <item>
          <text><![CDATA[<p><b>Patient Safety and Toxicology Modernization Act of 2016</b></p> This bill requires the Food and Drug Administration to issue and periodically update guidance on: (1) novel tools for testing the toxicology and efficacy of medications, and (2) three-dimensional human tissue models.]]></text>
          <updateDate>2016-12-07T05:00:00Z</updateDate>
          <name>Introduced in House</name>
          <versionCode>00</versionCode>
          <lastSummaryUpdateDate>2017-05-23T13:43:34Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in House</actionDesc>
          <actionDate>2016-12-07</actionDate>
        </item>
      </billSummaries>
    </summaries>
    <introducedDate>2016-12-07</introducedDate>
    <calendarNumbers />
    <title>Patient Safety and Toxicology Modernization Act of 2016</title>
    <notes />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 162, Number 176 (Wednesday, December 7, 2016)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. COLLINS of New York:H.R. 6463.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8 of the U.S. Constitution.[Page H7398]</pre>]]></constitutionalAuthorityStatementText>
    <updateDate>2018-11-21T21:23:34Z</updateDate>
    <committees>
      <billCommittees>
        <item>
          <systemCode>hsif00</systemCode>
          <subcommittees />
          <name>Energy and Commerce Committee</name>
          <type>Standing</type>
          <activities>
            <item>
              <date>2016-12-07T15:01:00Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <chamber>House</chamber>
        </item>
      </billCommittees>
    </committees>
    <sponsors>
      <item>
        <fullName>Rep. Collins, Chris [R-NY-27]</fullName>
        <lastName>Collins</lastName>
        <firstName>Chris</firstName>
        <middleName />
        <party>R</party>
        <bioguideId>C001092</bioguideId>
        <district>27</district>
        <byRequestType />
        <identifiers>
          <bioguideId>C001092</bioguideId>
          <lisID>2151</lisID>
          <gpoId />
        </identifiers>
        <state>NY</state>
      </item>
    </sponsors>
    <recordedVotes />
    <titles>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <title>Patient Safety and Toxicology Modernization Act of 2016</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <title>To direct the Secretary of Health and Human Services to issue guidance with respect to three-dimensional human tissue models, and for other purposes.</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Display Title</titleType>
        <title>Patient Safety and Toxicology Modernization Act of 2016</title>
      </item>
    </titles>
    <billType>HR</billType>
    <version>1.0.0</version>
    <cosponsors>
      <item>
        <district>7</district>
        <state>MO</state>
        <fullName>Rep. Long, Billy [R-MO-7]</fullName>
        <firstName>Billy</firstName>
        <middleName />
        <party>R</party>
        <sponsorshipDate>2016-12-07</sponsorshipDate>
        <lastName>Long</lastName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <identifiers>
          <lisID>2033</lisID>
          <bioguideId>L000576</bioguideId>
          <gpoId>8015</gpoId>
        </identifiers>
        <sponsorshipWithdrawnDate />
        <bioguideId>L000576</bioguideId>
      </item>
    </cosponsors>
    <createDate>2016-12-08T05:07:58Z</createDate>
    <relatedBills />
    <laws />
    <cboCostEstimates />
    <congress>114</congress>
    <originChamber>House</originChamber>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Medical tests and diagnostic methods</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInHouse>1</introducedInHouse>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
      <item>
        <actionCode>H11100</actionCode>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <links />
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <actionDate>2016-12-07</actionDate>
      </item>
      <item>
        <actionCode>Intro-H</actionCode>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <actionDate>2016-12-07</actionDate>
      </item>
      <item>
        <actionCode>1000</actionCode>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <actionDate>2016-12-07</actionDate>
      </item>
    </actions>
    <committeeReports />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

